Rentokil Initial falls 3.7% as investors look for progress in North America
Rentokil Initial shares fell 3.73% to 425.79 pence Thursday, extending a two-day slide to 5.6% and underperforming the FTSE 100. The company has not issued a new trading update since April, leaving investors focused on North American growth ahead of interim results on July 30. Rafael Carrasco will become North America chief executive on August 3. First-quarter revenue rose 4.3% to $1.677 billion.